Randomized Controlled Trial Evaluating AI-Guided 3D-Printed Surgical Guides Versus Conventional Surgery in Maxillofacial Trauma
Journal of Medicine and Dentistry · 15.10.2026 · 3 (2) · 30-39
DOI: 10.64951/jmdnt.2026.2.17 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medicine and Dentistry, online erschienen am 28.03.2026. Verfasst von Ayhan Yildirim und 2 weiteren Autor:innen.
Abstract (Originalsprache)
time, complication rates, and workflow efficiency.
Results
The AI-guided group demonstrated significantly higher surgical accuracy (1.1 ± 0.5 mm vs. 2.3 ± 0.9 mm, p < 0.001) and reduced operative time (75 ± 14 min vs. 105 ± 20 min, p < 0.001). Complication rates were lower in the intervention group (3.8% vs. 9.6%), although not statistically significant. Workflow standardization and intraoperative predictability were significantly improved.
Conclusion
AI-guided 3D-printed surgical guides significantly improve surgical accuracy and efficiency compared to conventional approaches, providing high-level clinical evidence for the integration of AI and additive manufacturing in maxillofacial trauma surgery.
Zitieren
APA
Yildirim, A., Hertach, R., & Yildirim, V. (2026). Randomized Controlled Trial Evaluating AI-Guided 3D-Printed Surgical Guides Versus Conventional Surgery in Maxillofacial Trauma. Journal of Medicine and Dentistry, 3(2), 30-39. https://doi.org/10.64951/jmdnt.2026.2.17
Vancouver
Yildirim A, Hertach R, Yildirim V. Randomized Controlled Trial Evaluating AI-Guided 3D-Printed Surgical Guides Versus Conventional Surgery in Maxillofacial Trauma. Journal of Medicine and Dentistry. 2026;3(2):30-39. doi:10.64951/jmdnt.2026.2.17
BibTeX
@article{Yildirim2026,
author = {Yildirim, Ayhan and Hertach, René and Yildirim, Vedat},
title = {Randomized Controlled Trial Evaluating AI-Guided 3D-Printed Surgical Guides Versus Conventional Surgery in Maxillofacial Trauma},
journal = {Journal of Medicine and Dentistry},
year = {2026},
volume = {3},
number = {2},
pages = {30--39},
doi = {10.64951/jmdnt.2026.2.17}
}
EUVIMED